Free Trial

Cogent Biosciences (COGT) Stock Price, News & Analysis

Cogent Biosciences logo
$9.35 +1.77 (+23.35%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$9.39 +0.04 (+0.43%)
As of 07/7/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cogent Biosciences Stock (NASDAQ:COGT)

Key Stats

Today's Range
$8.80
$10.23
50-Day Range
$4.69
$9.35
52-Week Range
$3.72
$12.61
Volume
31.65 million shs
Average Volume
1.46 million shs
Market Capitalization
$1.06 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.33
Consensus Rating
Moderate Buy

Company Overview

Cogent Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

COGT MarketRank™: 

Cogent Biosciences scored higher than 52% of companies evaluated by MarketBeat, and ranked 503rd out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cogent Biosciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cogent Biosciences has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Cogent Biosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Cogent Biosciences are expected to grow in the coming year, from ($2.42) to ($2.20) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cogent Biosciences is -5.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cogent Biosciences is -5.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cogent Biosciences has a P/B Ratio of 7.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Cogent Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    15.65% of the float of Cogent Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Cogent Biosciences has a short interest ratio ("days to cover") of 9.9.
  • Change versus previous month

    Short interest in Cogent Biosciences has recently increased by 15.44%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cogent Biosciences does not currently pay a dividend.

  • Dividend Growth

    Cogent Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.65% of the float of Cogent Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Cogent Biosciences has a short interest ratio ("days to cover") of 9.9.
  • Change versus previous month

    Short interest in Cogent Biosciences has recently increased by 15.44%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cogent Biosciences has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 20 news articles for Cogent Biosciences this week, compared to 4 articles on an average week.
  • Search Interest

    Only 3 people have searched for COGT on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.
Receive COGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter.

COGT Stock News Headlines

Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.
Q2 Earnings Estimate for COGT Issued By Lifesci Capital
See More Headlines

COGT Stock Analysis - Frequently Asked Questions

Cogent Biosciences' stock was trading at $7.80 at the beginning of 2025. Since then, COGT shares have increased by 19.9% and is now trading at $9.35.

Cogent Biosciences, Inc. (NASDAQ:COGT) released its quarterly earnings results on Tuesday, May, 6th. The technology company reported ($0.52) earnings per share for the quarter, topping the consensus estimate of ($0.56) by $0.04.

Shares of COGT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cogent Biosciences investors own include Visa (V), Tesla (TSLA), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Netflix (NFLX), NVIDIA (NVDA) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
5/06/2025
Today
7/07/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:COGT
Fax
N/A
Employees
80
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.33
High Stock Price Target
$28.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+74.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$255.86 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.32 per share
Price / Book
7.08

Miscellaneous

Free Float
105,556,000
Market Cap
$1.06 billion
Optionable
Optionable
Beta
1.88
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:COGT) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners